Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JiyunZen Technology (Wuhan JiyunZen Tech Co., Ltd.) is a pharmaceutical and chemical solutions provider based in Wuhan, China. The company specializes in the manufacturing and global distribution of high-purity active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and custom chemical formulations. Its extensive product catalog features advanced therapeutic agents across various areas, including oncology (e.g., Olaparib, Trametinib), cardiovascular health (e.g., Landiolol, Sacubitril), and metabolic disorders (e.g., Tirzepatide). JiyunZen serves a diverse international clientele in over 17 countries, supporting both early-stage drug discovery and commercial-scale production. The company is recognized for its focus on stringent quality control systems and sustainable manufacturing processes to ensure compliance with international standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JiyunZen Technology.